T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab

PURPOSE: Ado-trastuzumab emtansine (T-DM1) is currently approved for treatment in patients with human epidermal growth factor receptor 2 (HER2)–positive, metastatic breast cancer (MBC) who previously received trastuzumab and a taxane. However, there are no data on the activity of T-DM1 in patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Dzimitrowicz, Hannah, Berger, Michael, Vargo, Craig, Hood, Annette, Abdelghany, Osama, Raghavendra, Akshara Singareeka, Tripathy, Debu, Valero, Vicente, Hatzis, Christos, Pusztai, Lajos, Murthy, Rashmi
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6075965/
https://ncbi.nlm.nih.gov/pubmed/27298406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.3624
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados